Mouse L929 cells were incubated with antibody-targeted liposomes containing oligodeoxyribonucleotides (oligomers). When the oligomer was a 15-mer complementary to the 5'-end region of the mRNA encoding the N protein of vesicular stomatitis virus, the cells became less permissive for multiplication of that virus; >95% reduction of viral multiplication was achieved. Protection was not seen for "empty" liposomes, liposomes containing a random oligomer sequence, or liposomes containing a sequence complementary to the 5' end of c-myc protooncogene mRNA targeted by the same antibody, nor was it seen when the liposomes containing the N-protein antisense oligomer were targeted by an antibody that does not bind to L929 cells. Antibody-bearing liposomes containing antisense oligomers thus have a double specificity: a particular cell selected by the targeting antibody on the liposome and a particular mRNA in the cell selected by sequence complementarity with the liposome-encapsulated oligomer.
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Nonencapsulated oligomers are sensitive to nucleases and usually must be administered to cells at high concentrations. Oligomers encapsulated in liposomes resist DNase and are active in amounts 1-2 orders of magnitude lower than for those reported for unencapsulated oligomer sequences.
Selective inhibition of gene expression can be achieved by the introduction into cells of interfering oligomer sequences complementary to cellular mRNA or to viral RNA or DNA ("antisense" sequences). This technology offers the potential for studying the role of individual proteins in living cells and may have therapeutic potential. Several factors limit use of antisense reagents, the most important of which are their susceptibility to degradation by nucleases and their poor penetration into cells, so that high concentrations (5-500 ,uM, depending on the system) of oligomer in the medium have been reported to be required for detectable inhibition (for review see ref. 1) .
Among different methods investigated to overcome these problems, the use of nonionic methylphosphate oligomers has proved efficient in the inhibition of vesicular stomatitis virus (VSV) (2), herpes simplex virus (3), and human immunodeficiency virus (4) multiplication, but these oligomers usually also need to be used at high concentrations (1) . One of our laboratories has shown that conjugation to poly(Llysine) of oligomers complementary to the 5' region of the RNA encoding the N protein of VSV was capable of increasing the effect of the antisense reagent to an activity in the nanomolar range against the multiplication of VSV (5) . However, these reagents do not associate specifically with cells and can be toxic to some cell lines. Further, the polylysinecoupled oligomer sequence remains sensitive to degradation by nucleases. We examined an alternative strategy for augmenting the cell association and enhancing both the resistance to degradation of oligomers and their entry into cells.
Macromolecules may be stably encapsulated in liposomes, which, by virtue of their limited permeability, restrict access by the milieu and protect their contents against enzymatic degradation. Liposomes may, in addition, be coupled to various ligands, including monoclonal antibodies or protein A, that permit their targeting to specific cell populations. Depending on the target molecule and cell, these liposomes may be taken up and release the encapsulated product intracellularly. We have previously shown that liposomes can be used for intracellular delivery of low molecular weight drugs and of nucleotide-based material such as (2'-5')A, (6) and the RNA duplex poly(rI)'poly(rC) (7) . In the present study we demonstrate the use of antibody-targeted liposomes for intracellular delivery of oligomers complementary to the 5' region of the N-protein mRNA of VSV. These liposome antisense reagents are active at low concentrations, resist nuclease degradation, retain their target sequence specificity, and can be directed to selected cell populations in vitro. (14) .
MATERIALS AND METHODS
Incubation of L929 Cells and Virus. Cells (2 x 105 per well in 24-well tissue culture plates) were incubated for various periods of time with liposome-encapsulated oligomers at the required concentration and with relevant (H-2K-specific) or control (HLA-specific) monoclonal antibodies (5 ,g/ml).
The cells were then infected with VSV at a multiplicity of infection (moi) of 1 and were frozen at -20°C 18 hr later. Virus was then titrated as described (8) .
VSV Protein Synthesis in Cultured Cells. VSV protein synthesis was evaluated in monolayer cultures of L929 cells (2 x 10 cells per well). The cells were incubated with liposome-encapsulated oligomers (2 ,uM) and H-2K-specific mAb (5 ,ug/ml) for 12 hr before infection with VSV at a moi of 5. Ten hours after infection, the medium was removed and the cells were incubated for 30 min in methionine-free medium supplemented with 10% (vol/vol) dialyzed fetal bovine serum and [35S]methionine (20 ,uCi/ml; 1 ,Ci = 37 kBq). The cells were then lysed in 1% (wt/vol) sodium dodecyl sulfate (SDS) and proteins were precipitated in 8% (wt/vol) trichloroacetic acid. After centrifugation the pellets were washed with diethyl ether, solubilized in sample loading buffer (4 M urea/80 mM Tris HCl, pH 6.8/2% SDS/50 mM 2-mercaptoethanol), and electrophoresed in a 10% (wt/vol) polyacrylamide gel (15) . Fluorography was performed as described (16 (Fig. 2) .
The protective effect was strictly dependent on the use of an antibody specific for the H-2K molecules expressed by the target cell. When cells were incubated with VSV liposomes in the absence of antibody or in the presence of an HLAspecific antibody, no inhibition of viral multiplication was observed (Fig. 3) .
The effect of VSV liposomes on protein synthesis in infected cells was also evaluated. L929 cells were incubated with H-2K-specific antibody and sufficient VSV liposomes so that the amount of VSV antisense oligomer in culture was 2 ,uM. Twelve hours later cultures were infected with VSV, and after 10 hr the effect on incorporation of [35S]methionine into viral proteins was determined. We observed (Fig. 4) The resistance of the encapsulated antisense sequence to degradation by DNase was evaluated. Cells were incubated with or without DNase I (Escherichia coli, Sigma) at 20 units/ml. To some wells was added the 15-mer VSV antisense oligomer coupled to polylysine, which was previously shown to inhibit VSV infection (5) . Other wells received the VSV antisense in protein A-bearing liposomes, together with H-2K-specific antibody at 5 ug/ml. After 5 hr, virus was added, and the virus titer was determined after additional incubation for 18 hr. The action of the VSV antisense sequence coupled to polylysine was completely inhibited by the DNase, but there was little or no effect on the antiviral activity of VSV liposomes (Fig. 5) .
DISCUSSION
The VSV and myc antisense oligomer sequences used in these experiments were selected because of their activity in inhibiting synthesis of the complementary proteins in other studies (5, 17) . The suitability of a sequence for antisense intervention may depend on many factors, including the function of the target protein and the concentration, stability, and accessibility of the RNA encoding it, though the mechanism(s) of antisense action are not entirely understood. The 3' ribonucleotide group on the oligomers (9) was included for the purpose of improving the efficiency of the covalent coupling in earlier work from one of our groups showing action of polylysine-coupled oligomers (5 free 3'-ribonucleotide oligomer has about the same activity as that reported for conventional oligomers (inhibition at 40 ,uM), the addition of the ribonucleotide seems to have little effect on its stability.
In this study a liposome-encapsulated antisense oligomer specific for viral mRNA, but not a nonsense oligomer or an oligomer specific for c-myc mRNA (17) , specifically reduced virus production in vitro. The amount of liposomeencapsulated antisense oligomer required for activity was 100 times lower than for the nonencapsulated oligomer. Class I molecules, encoded by genes of the MHC and expressed at variable levels on practically all nucleated cells, were used to mediate cell association of liposomes, with the specificity of action depending on the encapsulated oligomer sequence. In the presence of antibodies to the class I molecules expressed on L cells, protein A-bearing liposomes will bind to these molecules and be internalized by endocytosis. Nonspecific association between cells and protein A-bearing liposomes is very low in the absence of a ligand that becomes cell-bound (18) , and inhibitory effects were not seen in these conditions. Although liposomes are diluted in the medium and have only limited encapsulated volume, they contain concentrated oligomers and, in the presence of the appropriate ligand, accumulate at the cell surface. In the present experiments, excess liposomes and antibodies remained in the culture throughout the incubation, and multiple rounds of internalization were possible. High ratios ofantisense to coding (sense) sequences may be necessary for efficient antisense action, but at the present time we cannot estimate the efficiency of the process of transfer offunctional oligomers to their intracellular site of action. The liposomes used in these studies are not known to fuse with cell membranes (19) , and a large fraction of the endocytosed oligomers may be degraded in lysosomes.
The fate of liposomes taken up by receptor-mediated endocytosis is determined by the fate of the cell-surface molecules to which they bind. This may depend on both the cell type and the target molecule. Liposomes bound to MHC-encoded class I target molecules on L cells are internalized via noncoated pits (20) , whereas the same molecules on T lymphoid cells are internalized via coated pits (21) . The role of the compartment in which antisense oligomers enter into cells in relation to their capacity to regulate the translation of their complementary mRNAs is an area for further study.
The protection against degradation, the cell specificity, and the enhanced intracellular delivery made possible by antibody targeting provide a convenient means of introducing oligomer sequences into cells and will help us to understand the relationship between expression and function of the targeted RNAs. The ability to inhibit viral proliferation needs to be tested in a number of models to determine whether this technology may offer potential for therapeutic applications.
